Study held to see the effect of Ayurvedic medicine in obesity
Phase 2
- Conditions
- Health Condition 1: E663- Overweight
- Registration Number
- CTRI/2021/11/037812
- Lead Sponsor
- Snehal Dnyaneshwar Pansare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with the BMI above 25 and up to 40.
2.AGE ââ?¬â?? between 18-60 years of both gender.
3.Selection of patient will be irrespective of gender, religion and socio-economical class.
4.Patients willing to take Ayurvedic treatment for Sthaulya will be selected.
Exclusion Criteria
1.Known pregnant and lactating woman will be excluded.
2.Patients with Cardiac complications , Renal complications malignancy will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect of Ayurvedic formulation in reduction of weight.Timepoint: 21 days study with 3 follow ups( 0,7,14,21)
- Secondary Outcome Measures
Name Time Method 1.To study the New etiological factors in present era. <br/ ><br>2. To observe any side effects. <br/ ><br>3.To study the effect of Ayurvedic formulation in symptoms of sthaulya.Timepoint: 21 days study with 3 follow ups( 0,7,14,21)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Ayurvedic formulations efficacy in reducing adipogenesis in Sthaulya (Obesity)?
How does the Ayurvedic intervention in CTRI/2021/11/037812 compare to GLP-1 receptor agonists in weight management outcomes?
Are there specific biomarkers associated with metabolic syndrome that predict response to Ayurvedic therapies in E663 overweight patients?
What adverse events are commonly reported with Ayurvedic obesity treatments and how do they compare to orlistat or semaglutide?
What combination approaches involving Ayurvedic medicine and conventional anti-obesity drugs are being explored for enhanced therapeutic efficacy?